{"entity":{"id":"nct03463252","kind":"trial","name":"Value of LNG-IUS as Fertility-preserving Treatment of EAH and EC","aka":[],"tldr":"A phase 2/3 trial of Progestins in Endometrial cancer, run by West China Second University Hospital, now recruiting.","summary":"Value of LNG-IUS as Fertility-preserving Treatment of EAH and EC is a phase 2/3 interventional study registered as NCT03463252 by West China Second University Hospital, with 224 participants planned, started 2018-04-01 and due to reach its primary completion in 2025-12-30. Interventions recorded: Progesterone, Mirena®, GnRH agonist. Conditions recorded: Endometrial Cancer, Atypical Endometrial Hyperplasia.\n\nLinked to the drug Progestins because the registry names it among its interventions and Endometrial cancer among its conditions. Registry record only: no result has been read by an editor.","status":"recruiting","asOf":"2026-09-22","links":[{"label":"ClinicalTrials.gov NCT03463252","url":"https://clinicaltrials.gov/study/NCT03463252"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["endometrial"],"sections":[],"technologies":[],"targets":[],"drugs":["megestrol-progestins"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT03463252","phase":"2/3","setting":"Value of Levonorgestrel-Releasing Intrauterine System (LNG-IUS) in the Fertility-preserving Treatment of Atypical Endometrial Hyperplasia and Early Endometrial Carcinoma","sponsor":"West China Second University Hospital","enrolled":224,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct03463252/","neighbours":{"cancer":[{"id":"endometrial","kind":"cancer","name":"Endometrial cancer","route":"/cancers/endometrial/"}],"drug":[{"id":"megestrol-progestins","kind":"drug","name":"Progestins (megestrol acetate, medroxyprogesterone, levonorgestrel IUD)","route":"/drugs/megestrol-progestins/"}]}}